The U.S. Food & Drug Administration (FDA) said a CBD-based treatment for opioid use disorder can be used in clinical trials, Ananda Scientific Inc., the drug’s maker, announced this week. Ananda Scientific said the FDA granted an investigational drug designation (IND) for Nantheia ATL5, a liquid administered through the biotech pharma company’s proprietary delivery technology. The IND […]